Table 1. Clinical characteristics of patients with COVID-19.
| Disease severitya | Group M | Group S | |||||
|---|---|---|---|---|---|---|---|
| Mild | Moderate | Severe | Critical | ||||
| Patient number (n = 59) | 39% (23/59) | 36% (21/59) | 19% (11/59) | 7% (4/59) | |||
| Male, % | 78% (18/23) | 57% (12/21) | 100% (11/11) | 75% (3/4) | |||
| Age range (average) | 24–82 (43.3) | 18–80 (54.9) | 6–86 (66.5) | 67–79 (75.3) | |||
| Past medical history | |||||||
| Hypertension | 9% (2/23) | 14% (3/21) | 9% (1/11) | 50% (2/4) | |||
| Hyperlipidemia | 9% (2/23) | 5% (1/21) | 0% (0/11) | 0% (0/4) | |||
| Diabetes | 0% (0/23) | 14% (3/21) | 18% (2/11) | 25% (1/4) | |||
| Cancer | 9% (2/23) | 0% (0/21) | 18% (2/11) | 25% (1/4) | |||
| Renal failure | 0% (0/23) | 0% (0/21) | 9% (1/11) | 25% (1/4) | |||
| Others, None known | 83% (19/23) | 76% (16/21) | 64% (7/11) | 50% (2/4) | |||
| Sample percentage (n = 146) | 24% (35/146) | 34% (49/146) | 29% (43/146) | 13% (19/146) | |||
| Days from onset | |||||||
| 0–6 (n = 25) | 7 | 8 | 8 | 2 | |||
| 7–13 (n = 28) | 7 | 11 | 10 | 0 | |||
| 14–20 (n = 26) | 9 | 8 | 7 | 2 | |||
| 21–27 (n = 24) | 4 | 8 | 6 | 6 | |||
| 28–34 (n = 15) | 3 | 5 | 5 | 2 | |||
| 35–41 (n = 13) | 4 | 3 | 4 | 2 | |||
| >42 (n = 15) | 1 | 6 | 3 | 5 | |||
aWHO criteria.